Clinical Trial

Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea

Study acronym: LIBERTÀ
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study if to evaluate the efficacy and safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-12.
Trial Details
NCT Number NCT06268054
Lead Sponsor EMS
Conditions Primary Dysmenorrhea
Enrollment 78 participants
Start Date 2025-02
Primary Completion 2027-02 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2024-02-22